Erythema, skin cancer risk, and sunscreens
M. F. Naylor
Ultraviolet-induced erythema is now recognized as an important clinical
marker for skin cancer risk. People with a history of repeated erythematous
exposures to sunlight are more likely to develop both melanoma and
nonmelanoma skin cancers. Is erythema the most important thing we need to
be concerned about in terms of protecting the public from the harmful
effects of sunlight? What do we know about UV-induced erythema, and why is
it a powerful influence on skin cancer risk?
